Pfizer studying coronavirus oral antiviral therapeutic
March 24 2021, 08:00
Pfizer has begun a U.S.-based clinical trial examining the safety and tolerability of an oral antiviral therapeutic against the virus causing COVID-19 disease, the company announced Tuesday.
Pfizer has begun a U.S.-based clinical trial examining the safety and tolerability of an oral antiviral therapeutic against the virus causing COVID-19 disease, the company announced Tuesday.
Source:
FOX News